ENDRA Life Sciences (NDRA) Short Interest Ratio & Short Volume $4.33 -0.22 (-4.84%) Closing price 02/21/2025 03:46 PM EasternExtended Trading$4.67 +0.34 (+7.94%) As of 02/21/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ENDRA Life Sciences Short Interest DataENDRA Life Sciences (NDRA) has a short interest of 33,200 shares, representing 6.18% of the float (the number of shares available for trading by the public). This marks a -15.74% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 13,480 shares to cover all short positions.Current Short Interest33,200 sharesPrevious Short Interest39,400 sharesChange Vs. Previous Month-15.74%Dollar Volume Sold Short$167,792.80Short Interest Ratio0.4 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares540,000 sharesFloat Size536,800 sharesShort Percent of Float6.18%Today's Trading Volume7,406 sharesAverage Trading Volume13,480 sharesToday's Volume Vs. Average55% Short Selling ENDRA Life Sciences? Sign up to receive the latest short interest report for ENDRA Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNDRA Short Interest Over TimeNDRA Days to Cover Over TimeNDRA Percentage of Float Shorted Over Time ENDRA Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202533,200 shares $167,792.80 -15.7%6.2%0.4 $5.05 1/15/202539,400 shares $236,400.00 -24.5%7.3%0.2 $6.00 12/31/202452,200 shares $326,772.00 +15.2%9.7%0.2 $6.26 12/15/202445,300 shares $193,431.00 -32.3%8.4%0.2 $4.27 11/30/202466,900 shares $381,999.00 +6.9%12.5%0.3 $5.71 11/15/202462,600 shares $284,204.00 +160.8%11.7%0.2 $4.54 10/31/202424,000 shares $211,260.00 -96.7%4.6%0.1 $8.80 10/15/2024717,700 shares $149,999.30 +167.7%4.0%0.1 $0.21 9/30/2024268,100 shares $53,888.10 +324.2%1.5%0.1 $0.20 9/15/202463,200 shares $14,536.00 -65.7%0.4%0 $0.23 Get the Latest News and Ratings for NDRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024184,200 shares $70,493.34 +11.7%1.0%0.1 $0.38 8/15/2024164,900 shares $21.44 million -24.5%11.4%0.1 $130.00 7/31/2024218,500 shares $17,152.25 -5.9%N/A0 $0.08 7/15/2024232,100 shares $21,260.36 -29.3%N/A0 $0.09 6/30/2024328,200 shares $31,868.22 -75.0%N/A0 $0.10 6/15/20241,310,000 shares $135,716.00 +371.9%N/A0.1 $0.10 5/31/2024277,600 shares $74,674.40 +165.1%2.6%0 $0.27 5/15/2024104,700 shares $30,415.35 +2,517.5%1.0%0.6 $0.29 4/30/20244,000 shares $1,131.60 -47.4%0.0%0 $0.28 4/15/20247,600 shares $1,991.20 -75.2%0.1%0 $0.26 3/31/202430,600 shares $17,748.00 -36.9%0.3%0.2 $0.58 3/15/202448,500 shares $48,500.00 -11.3%0.5%0.3 $1.00 2/29/202454,700 shares $61,264.00 +86.1%0.5%0.4 $1.12 2/15/202429,400 shares $33,810.00 +47.7%0.4%0.3 $1.15 1/31/202419,900 shares $20,895.00 -73.7%0.2%0.2 $1.05 1/15/202475,700 shares $98,410.00 -41.8%0.9%0.8 $1.30 12/31/2023130,000 shares $275,600.00 -25.5%1.6%1.4 $2.12 12/15/2023174,500 shares $251,280.00 -17.3%2.1%2.3 $1.44 11/30/2023211,100 shares $206,434.69 -11.8%2.6%1.9 $0.98 11/15/2023239,300 shares $227,335.00 -6.1%2.9%2.4 $0.95 10/31/2023254,900 shares $251,076.50 +56.5%3.5%2.2 $0.99 10/15/2023162,900 shares $169,416.00 +28.9%2.2%1.4 $1.04 9/30/2023126,400 shares $140,316.64 +175.4%1.7%1.1 $1.11 9/15/202345,900 shares $56,457.00 -37.1%0.6%0.4 $1.23 8/31/202373,000 shares $85,410.00 +5.5%1.0%1.2 $1.17 8/15/202369,200 shares $79,580.00 +61.7%0.9%1.1 $1.15 7/31/202342,800 shares $53,072.00 -20.0%0.6%0.8 $1.24 7/15/202353,500 shares $72,760.00 -36.5%0.7%0.8 $1.36 6/30/202384,300 shares $118,020.00 +13.2%1.2%1.3 $1.40 6/15/202374,500 shares $109,515.00 +40.0%1.0%1.4 $1.47Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y 5/31/202353,200 shares $78,204.00 +54.7%0.8%1.2 $1.47 5/15/202334,400 shares $44,032.00 -70.1%0.5%1 $1.28 4/30/2023114,900 shares $183,840.00 +61.2%1.9%3.9 $1.60 4/15/202371,300 shares $131,905.00 +124.2%2.4%5.7 $1.85 3/31/202331,800 shares $72,818.82 -7.8%1.1%2.6 $2.29 3/15/202334,500 shares $124,200.00 +24.1%1.2%2.6 $3.60 2/28/202327,800 shares $108,420.00 -7.6%0.9%1.3 $3.90 2/15/202330,100 shares $111,370.00 -9.1%1.0%1.4 $3.70 1/31/202333,100 shares $132,731.00 -23.2%1.1%1.4 $4.01 1/15/202343,100 shares $202,570.00 +28.3%1.4%1.8 $4.70 12/30/202233,600 shares $136,752.00 -54.4%1.1%1.4 $4.07 12/15/202273,600 shares $374,624.00 +173.6%2.4%3.2 $5.09 11/30/202226,900 shares $4,777.44 -95.5%0.9%2 $0.18 11/15/2022597,800 shares $119,679.56 +8.8%N/A2.2 $0.20 10/31/2022549,600 shares $126,408.00 -19.7%N/A1.9 $0.23 10/15/2022684,800 shares $208,521.60 -11.7%N/A2.1 $0.30 9/30/2022775,300 shares $237,241.80 +0.1%N/A2.1 $0.31 9/15/2022774,500 shares $278,820.00 +11.5%N/A1.9 $0.36 8/31/2022694,700 shares $202,643.99 -8.8%N/A1.5 $0.29 8/15/2022761,900 shares $275,045.90 +17.1%N/A1.3 $0.36 7/31/2022650,600 shares $178,784.88 -6.2%N/A0.8 $0.27 7/15/2022693,400 shares $163,919.76 -17.9%N/A0.6 $0.24 6/30/2022844,400 shares $196,745.20 +97.2%N/A0.3 $0.23 6/15/2022428,200 shares $102,768.00 -55.0%N/A0.1 $0.24 5/31/2022952,400 shares $219,052.00 +282.3%N/A0.3 $0.23 5/15/2022249,100 shares $49,570.90 -86.9%N/A0.1 $0.20 4/30/20221,900,000 shares $492,860.00 -12.0%N/A0.8 $0.26 4/15/20222,160,000 shares $559,440.00 +285.8%N/A0.9 $0.26 3/31/2022559,900 shares $218,361.00 +30.2%N/A0.4 $0.39 3/15/2022430,200 shares $167,778.00 +32.1%1.1%1.6 $0.39 2/28/2022325,600 shares $139,356.80 -11.2%0.8%1.2 $0.43 2/15/2022366,500 shares $160,893.50 +16.8%0.9%1.2 $0.44 1/31/2022313,900 shares $188,340.00 -38.4%0.8%1 $0.60 1/15/2022509,300 shares $352,944.90 -1.4%1.2%1.6 $0.69 12/31/2021516,400 shares $357,245.52 +5.2%1.3%1.7 $0.69 12/15/2021491,000 shares $374,142.00 -11.9%1.2%1.8 $0.76 11/30/2021557,200 shares $530,510.12 -45.4%1.4%2.2 $0.95 11/15/20211,020,000 shares $1.36 million -15.0%2.5%4 $1.33 10/29/20211,200,000 shares $1.90 million +9.1%2.9%4.4 $1.58 10/15/20211,100,000 shares $1.74 million -10.6%2.7%4.2 $1.58 9/30/20211,230,000 shares $2.13 million +0.8%3.0%4.2 $1.73 9/15/20211,220,000 shares $2.12 million +1.7%3.0%3.5 $1.74 8/31/20211,200,000 shares $2.28 million +53.4%2.9%3.1 $1.90 8/13/2021782,100 shares $1.27 million -27.6%1.9%1.9 $1.62 7/30/20211,080,000 shares $1.94 million +30.6%2.7%2.5 $1.80 7/15/2021827,100 shares $1.55 million +7.9%2.0%1.5 $1.87 6/30/2021766,800 shares $1.67 million -4.1%1.9%1.2 $2.18 6/15/2021799,200 shares $1.71 million +28.2%2.0%1 $2.14 5/28/2021623,400 shares $1.32 million -46.3%1.5%0.6 $2.12 5/14/20211,160,000 shares $2.30 million -10.8%N/A0.8 $1.98Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y 4/30/20211,300,000 shares $3.21 million -3.7%N/A0.7 $2.47 4/15/20211,350,000 shares $3.08 million +13.5%N/A0.6 $2.28 3/31/20211,190,000 shares $3.06 million +304.4%N/A0.4 $2.57 3/15/2021294,300 shares $735,750.00 -34.1%N/A0.1 $2.50 2/26/2021446,800 shares $1.10 million +19.6%N/A0.2 $2.46 2/12/2021373,700 shares $852,036.00 -61.8%N/A0.1 $2.28 1/29/2021979,400 shares $1.97 million +98.2%N/A0.4 $2.01 1/15/2021494,200 shares $499,142.00 +3.6%N/A0.3 $1.01 12/31/2020476,900 shares $355,290.50 -11.2%N/A0.9 $0.75 12/15/2020537,300 shares $482,925.24 -2.2%N/A1.7 $0.90 11/30/2020549,600 shares $467,434.80 +5.1%N/A3.2 $0.85 11/15/2020522,900 shares $441,327.60 -12.7%N/A3.7 $0.84 10/30/2020598,900 shares $430,070.09 +3.5%N/A4 $0.72 10/15/2020578,800 shares $421,655.80 +0.2%N/A2.6 $0.73 9/30/2020577,800 shares $422,660.70 -1.9%N/A1.9 $0.73 9/15/2020588,800 shares $471,040.00 -1.2%N/A1.4 $0.80 8/31/2020595,700 shares $488,474.00 -2.6%N/A1.2 $0.82 8/14/2020611,300 shares $562,396.00 +7.8%N/A1.2 $0.92 7/31/2020567,200 shares $558,692.00 -1.2%N/A1.1 $0.99 7/15/2020573,900 shares $511,230.12 +2.6%N/A1.1 $0.89 6/30/2020559,600 shares $570,792.00 -9.8%N/A1.4 $1.02 6/15/2020620,400 shares $536,708.04 +0.1%N/A2.1 $0.87 5/29/2020619,700 shares $570,124.00 -0.2%N/A2.7 $0.92 5/15/2020620,800 shares $444,058.24 -3.6%N/A3.4 $0.72 4/30/2020643,700 shares $499,511.20 +1.9%N/A4.4 $0.78 4/15/2020631,700 shares $553,116.52 +0.9%N/A6.8 $0.88 3/31/2020626,100 shares $525,924.00 -0.2%N/A5.5 $0.84 3/13/2020627,200 shares $439,040.00 -5.7%N/A4.9 $0.70 2/28/2020664,800 shares $518,544.00 +1.2%N/A4.6 $0.78 NDRA Short Interest - Frequently Asked Questions What is ENDRA Life Sciences' current short interest? Short interest is the volume of ENDRA Life Sciences shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 33,200 shares of NDRA short. 6.18% of ENDRA Life Sciences' shares are currently sold short. Learn More on ENDRA Life Sciences' current short interest. What is a good short interest percentage for ENDRA Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.18% of ENDRA Life Sciences' floating shares are currently sold short. Is ENDRA Life Sciences' short interest increasing or decreasing? ENDRA Life Sciences saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 33,200 shares, a decline of 15.7% from the previous total of 39,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ENDRA Life Sciences' float size? ENDRA Life Sciences currently has issued a total of 540,000 shares. Some of ENDRA Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ENDRA Life Sciences currently has a public float of 536,800 shares. How does ENDRA Life Sciences' short interest compare to its competitors? 6.18% of ENDRA Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to ENDRA Life Sciences: Predictive Oncology Inc. (9.55%), Aethlon Medical, Inc. (9.47%), Intelligent Bio Solutions Inc. (9.29%), NeuroMetrix, Inc. (0.18%), Meihua International Medical Technologies Co., Ltd. (1.23%), Cutera, Inc. (19.76%), QT Imaging Holdings, Inc. (1.89%), SeaStar Medical Holding Co. (5.37%), PAVmed Inc. (3.64%), Plus Therapeutics, Inc. (1.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short ENDRA Life Sciences stock? Short selling NDRA is an investing strategy that aims to generate trading profit from ENDRA Life Sciences as its price is falling. NDRA shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ENDRA Life Sciences? A short squeeze for ENDRA Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NDRA, which in turn drives the price of the stock up even further. How often is ENDRA Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NDRA, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies POAI Short Interest AEMD Short Interest INBS Short Interest NURO Short Interest MHUA Short Interest CUTR Short Interest QTI Short Interest ICU Short Interest PAVM Short Interest PSTV Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NDRA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NDRA Stock Alerts